C3U-34385-86500 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-28
Registered in v-safe
2022-12-16
Dose 1 — Pfizer-BioNTech
Co-administered: Flu
2023-01-13
Dose 2 — Pfizer-BioNTech
Co-administered: Flu
2023-03-10
Dose 3 — Pfizer-BioNTech
2023-03-22
Health check-in — day 7, dose 3, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2023-03-24
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-03-31
Survey response — day 21, dose 3, under 3
MedDRA: Candida infection, Ear infection — Feeling: Fair

MedDRA releases: 2024-11
2023-04-07
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-04-14
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-04-21
Health check-in — day 42, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-09
Survey response — 3 months, dose 3, under 3
MedDRA: Conjunctivitis, Viral upper respiratory tract infection — Feeling: Fair

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-12-16	Pfizer-BioNTech	Flu
2	2023-01-13	Pfizer-BioNTech	Flu
3	2023-03-10	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Candida infection	·	·	✓
SD	Conjunctivitis	·	·	✓
SD	Ear infection	·	·	✓
SD	Viral upper respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release